ACXP
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
8.16M
70 days until earnings call
FBIOP
Price
$9.47
Change
+$0.72 (+8.23%)
Updated
Jun 6 closing price
Capitalization
N/A
Interact to see
Advertisement

ACXP vs FBIOP

Header iconACXP vs FBIOP Comparison
Open Charts ACXP vs FBIOPBanner chart's image
Acurx Pharmaceuticals
Price$0.35
Change-$0.00 (-0.00%)
Volume$171.87K
Capitalization8.16M
Fortress Biotech
Price$9.47
Change+$0.72 (+8.23%)
Volume$23.9K
CapitalizationN/A
ACXP vs FBIOP Comparison Chart
Loading...
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACXP vs. FBIOP commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a StrongBuy and FBIOP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ACXP: $0.39 vs. FBIOP: $6.75)
Brand notoriety: ACXP and FBIOP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 100% vs. FBIOP: 195%
Market capitalization -- ACXP: $8.16M vs. FBIOP: $0
ACXP [@Biotechnology] is valued at $8.16M. FBIOP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 0 FA rating(s) are green whileFBIOP’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 0 green, 5 red.
  • FBIOP’s FA Score: 1 green, 4 red.
According to our system of comparison, FBIOP is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 7 TA indicator(s) are bullish while FBIOP’s TA Score has 5 bullish TA indicator(s).

  • ACXP’s TA Score: 7 bullish, 1 bearish.
  • FBIOP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than FBIOP.

Price Growth

ACXP (@Biotechnology) experienced а -5.60% price change this week, while FBIOP (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ACXP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBIOP YTD gains are higher at: 1.549 vs. ACXP (-52.334). ACXP has higher annual earnings (EBITDA): -14.1M vs. FBIOP (-108.52M). FBIOP has more cash in the bank: 58.9M vs. ACXP (3.71M). FBIOP has higher revenues than ACXP: FBIOP (62.5M) vs ACXP (0).
ACXPFBIOPACXP / FBIOP
Capitalization8.16MN/A-
EBITDA-14.1M-108.52M13%
Gain YTD-52.3341.549-3,379%
P/E RatioN/AN/A-
Revenue062.5M-
Total Cash3.71M58.9M6%
Total DebtN/A71.5M-
FUNDAMENTALS RATINGS
FBIOP: Fundamental Ratings
FBIOP
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPFBIOP
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
81%
Bearish Trend 12 days ago
56%
Momentum
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 12 days ago
59%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
56%
Advances
ODDS (%)
Bullish Trend 20 days ago
76%
Bullish Trend 20 days ago
63%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 18 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACXP has been loosely correlated with SLRN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ACXP jumps, then SLRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
-1.52%
SLRN - ACXP
34%
Loosely correlated
N/A
ALEC - ACXP
33%
Poorly correlated
+12.70%
SGMT - ACXP
29%
Poorly correlated
+1.19%
MGX - ACXP
28%
Poorly correlated
-0.60%
MGTX - ACXP
28%
Poorly correlated
+0.20%
More

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been closely correlated with HLVX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBIOP jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
-0.56%
HLVX - FBIOP
82%
Closely correlated
-1.61%
FBIO - FBIOP
26%
Poorly correlated
+3.83%
ACXP - FBIOP
10%
Poorly correlated
-1.52%
INDP - FBIOP
8%
Poorly correlated
-1.88%
ELTX - FBIOP
6%
Poorly correlated
+21.87%
More